In conclusion, although our results should be considered preliminary, our findings support that the investigation of the GHR polymorphism may prove beneficial in enhancing the personalized therapeutic approach of patients with acromegaly, including the prevention of acromegaly-related comorbidities, in the context of patients-tailored medicine. Here, GHR is linked to acromegaly.